Advertisement

Ads Placeholder
Loading...

F3 Uranium Corp.

FUUFFPNK
Energy
Uranium
$0.12
$-0.00(-1.12%)
U.S. Market is Open • 12:23

F3 Uranium Corp. Fundamental Analysis

F3 Uranium Corp. (FUUFF) shows weak financial fundamentals with a PE ratio of -18.87, profit margin of 0.00%, and ROE of -7.98%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position33.07%
PEG Ratio-0.37
Current Ratio6.68

Areas of Concern

ROE-7.98%
Operating Margin0.00%
We analyze FUUFF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 25.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
25.7/100

We analyze FUUFF's fundamental strength across five key dimensions:

Efficiency Score

Weak

FUUFF struggles to generate sufficient returns from assets.

ROA > 10%
-5.37%

Valuation Score

Excellent

FUUFF trades at attractive valuation levels.

PE < 25
-18.87
PEG Ratio < 2
-0.37

Growth Score

Weak

FUUFF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

FUUFF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.14
Current Ratio > 1
6.68

Profitability Score

Weak

FUUFF struggles to sustain strong margins.

ROE > 15%
-797.98%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is FUUFF Expensive or Cheap?

P/E Ratio

FUUFF trades at -18.87 times earnings. This suggests potential undervaluation.

-18.87

PEG Ratio

When adjusting for growth, FUUFF's PEG of -0.37 indicates potential undervaluation.

-0.37

Price to Book

The market values F3 Uranium Corp. at 1.31 times its book value. This may indicate undervaluation.

1.31

EV/EBITDA

Enterprise value stands at -14.55 times EBITDA. This is generally considered low.

-14.55

How Well Does FUUFF Make Money?

Net Profit Margin

For every $100 in sales, F3 Uranium Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-7.98 in profit for every $100 of shareholder equity.

-7.98%

ROA

F3 Uranium Corp. generates $-5.37 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.37%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

FUUFF converts -12.05% of its market value into free cash.

-12.05%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-18.87

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.37

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.31

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.14

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.68

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.08

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

-0.09

vs 25 benchmark

How FUUFF Stacks Against Its Sector Peers

MetricFUUFF ValueSector AveragePerformance
P/E Ratio-18.8721.19 Better (Cheaper)
ROE-7.98%948.00% Weak
Net Margin0.00%-73259.00% (disorted) Weak
Debt/Equity0.14-0.48 (disorted) Distorted
Current Ratio6.686.31 Strong Liquidity
ROA-5.37%-10913945.00% (disorted) Weak

FUUFF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews F3 Uranium Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Value, Commodity

EPS CAGR

N/A

Industry Style: Cyclical, Value, Commodity

FCF CAGR

N/A

Industry Style: Cyclical, Value, Commodity

Fundamental Analysis FAQ